[1] |
FANG Zhie, LI Chengxian, BAI Zhaofang, ZHAO Xu, WANG Jiabo, XIAO Xiaohe.
Investigation of objectivity in the relationship between aristolochic acid and hepatocellular carcinoma
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 20-24.
|
[2] |
LIU Huan, YUAN Hui, YIN Jingjing, LIU Mengya, QIN Xiujun, LI Jianguo.
General toxicology of Yiya Jianpi jel among juvenile animals
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 416-422.
|
[3] |
KE Bingbing, LI Yan, WANG Pinghui, XU Xiaoling, SHEN Jiate, LYU Xiaojun.
Evaluation of anaphylactoid reactions induced by human immunoglobulin for intravenous injection(pH 4.0) based on mouse auricular blue staining experiments
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1357-1361.
|
[4] |
TAN Liyuan, CAI Tong, WANG Yan.
Research progress in quantitative analysis methods for chemical reference substances
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1209-1216.
|
[5] |
ZHONG Yingying, WANG Zhao, ZUO Tiantian, LI Yaolei, LI Hailiang, MA Shuangcheng.
Research progress on detection and risk assessment of exogenous heavy metals and related elements in Codonopsis Radix
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1309-1315.
|
[6] |
WANG Xin, SUN Li, WANG Chao, LI Lulu, WANG Sanlong, LIU Jiajia, TIAN Chao, LI Xiaopeng, GENG Xingchao.
Biodistribution of oncolytic virus HSV-1 expressing human PD-1 antibody in cynomolgus macaques
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 12-18.
|
[7] |
WANG Qi, WEN Hairuo, MA Shuangcheng.
Screening of hepatotoxic components in Polygonum multiflorum by taking FXR nuclear receptors as targets
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(6): 630-634.
|
[8] |
WANG Qi, WEN Hairuo, YANG Jianbo, WANG Ying, LI Yanyi, MA Shuangcheng, ZHANG Yujie.
Study on the components of Polygonum multiflorum aqueous extract in rats after long-term administration
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(6): 620-625.
|
[9] |
WANG Wen, LIU Mei, HE Qiao, TIAN Chunhua, SONG Haibo, WANG Tao, TAN Jing, REN Yan, GAO Pei, PENG Xiaoxia, WEN Zehuai, SHU Xiaochen, ZOU Kang, SHEN Chuanyong, SUN Xin.
Expert consensus on design and statistical analysis to evaluate drug safety using routinely collected health data
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 7-12.
|
[10] |
QIAO Rui, LIU Yuqiang, ZHUO Lin, MENG Ruogu, SUN Feng, ZHAN Siyan.
Application Scope of Real-World Data in Post-Marketing Drug Safety Monitoring and Evaluation for Drug Safety
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(7): 620-623.
|
[11] |
WANG Xin, MIAO Yufa, HUO Yan, WANG Sanlong, ZHOU Xiaobing, GENG Xingchao.
Pre-Clinical Evaluation of Oncolytic Virus Drugs
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(6): 597-600.
|
[12] |
ZUO Tiantian, JIN Hongyu, WANG Zhao, YU Kunzi, KANG Shuai, PANG Yu, SUN Lei, MA Shuangcheng.
Safety Evaluation of Heavy Metals and Harmful Elements in Earthworms
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(5): 450-453.
|
[13] |
XUE Xue, JIN Xinyan, LU Chunli, DAI Ning, LIU Jianping.
Application of Real-World Study Designs in Post-Marketing Evaluation of Drug Safety
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(11): 1025-1028.
|
[14] |
GAO Yunjuan, ZHAO Xu, BAI Zhaofang, WANG Jiabo, ZHAN Xiaoyan, GUO Yuming, XIAO Xiaohe.
Prevention and Control of Safety Risks of Traditional Chinese Medicine Based on Indirect Knowledge of Toxicity
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(11): 1004-1008.
|
[15] |
XUE Xiaola, XIA Yuchao, LI Chaofeng, CHEN Yuanyuan.
Safety Comparison of Foscarnet and Ganciclovir in the Treatment of Cytomegalovirus Infection with AIDS
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(1): 38-42.
|